Abstract
Background: Parkinson's disease (PD) is a neurodegenerative disease that can lead to impaired motor function and execution of activities of daily living (ADL). Since clinicians typically can only observe patients' symptoms during visits, prescribed medication schedules may not reflect the full range of symptoms experienced throughout the day. Therefore, objective tools are needed to provide comprehensive symptom data to optimize treatment. One such tool is the Parkinson's KinetiGraph® (PKG), a wearable sensor that measures motor symptoms of Parkinson's disease.Objective: To build a mathematical model to determine if PKG data measuring Parkinson's patients' motor symptoms can predict patients' ADL impairment.Methods: Thirty-four patients with PD wore the PKG device for 6 days while performing their ADL. Patients' PKG scores for bradykinesia and dyskinesia, as well as their responses to a questionnaire asking if their ADL-level had been impacted by various motor symptoms, were used to build a multiple regression model predicting the patients' Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part II scores.Results: Calculation of bradykinesia score response to medication showed that using a dosage response time of 30 min yielded a greater bradykinesia response than when the response time was set to 40, 50, 60, 70, 80, or 90 min. The overall multiple regression model predicting MDS-UPDRS part II score was significant (R2 = 0.546, p < 0.001).Conclusion: The PKG's ability to provide motor symptom data that correlates with clinical measures of ADL impairment suggests that it has strong potential as a tool for the assessment and management of Parkinson's disease motor symptoms.
Highlights
Parkinson’s disease (PD) is a neurodegenerative disease that affects more than 10 million people worldwide
The disease is characterized by motor symptoms such as tremor, rigidity, bradykinesia, motor complications such as dyskinesia, and non-motor symptoms such as cognitive difficulties [1]
Wearable sensors are capable of measuring several various Parkinsonian motor symptoms and complications, such as bradykinesia, dyskinesia, and tremors [2]
Summary
Parkinson’s disease (PD) is a neurodegenerative disease that affects more than 10 million people worldwide. Wearable sensors can provide objective symptom data that can help clinicians modify medications to more effectively manage symptoms of Parkinson’s disease [4, 5]. While studies involving these sensors often compare device results to clinical assessments, to our knowledge, no study so far has analyzed device results in conjunction with patients’ subjective experiences regarding their motor symptoms [6,7,8]. Objective tools are needed to provide comprehensive symptom data to optimize treatment One such tool is the Parkinson’s KinetiGraph® (PKG), a wearable sensor that measures motor symptoms of Parkinson’s disease
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
